Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline-Reference-Cited by-同舟云学术

Jitteriness/Anxiety Syndrome Developing Immediately following Initiation of Oral Administration of Sertraline

Published:2017 Issue: Volume:2017 Page:1-2
ISSN:2090-682X
Container-title:Case Reports in Psychiatry
language:en
Short-container-title:Case Reports in Psychiatry

Author:

Nakamura Toshinori¹^ORCID,Sugiyama Nobuhiro¹²,Sasayama Daimei¹,Hagiwara Tetsuya¹,Washizuka Shinsuke¹

Affiliation:

1. Department of Psychiatry, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan

2. Department of Psychiatry, Shinshu University School of Health Sciences, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan

Abstract

Here, we report our experience with patients in whom jitteriness/anxiety syndrome developed immediately following the start of oral sertraline administration. Administration was discontinued in these patients on day 2, and the jitteriness/anxiety syndrome improved the following day. Jitteriness/anxiety syndrome may develop immediately following oral administration of even low doses of sertraline, and improvement can be expected if sertraline is promptly discontinued.

Publisher

Hindawi Limited

Subject

Psychiatry and Mental health

Link

http://downloads.hindawi.com/journals/crips/2017/1319505.pdf

Reference5 articles.

1. Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial

2. Antidepressant-induced jitteriness/anxiety syndrome: systematic review

3. Sertraline-Induced Behavioral Activation During the Treatment of an Adolescent With Major Depression

4. Acute Maniform Reaction to a Single Dose of Escitalopram in a Social Phobic Patient – An Atypical Jitteriness Syndrome?